Trump Announces Health Care Records System for Consumers
'Today the dream of easily transportable, electronic medical records finally becomes a reality,' Mr. Trump said at a White House event that included the leaders of dozens of technology companies.
The administration is working with some of the largest American companies on the record-keeping system, including Google, Amazon, Apple and OpenAI. The Centers for Medicare and Medicaid Services will oversee the effort.
Many health care providers already allow patients to upload their medical information and schedule appointments through phone apps and online portals.
Mr. Trump and top federal health officials said the information-sharing program would be an effective replacement for a system that often involves arduous and redundant paperwork that patients fill out when visiting different providers.
The system, which aims in part to help Americans with diabetes and obesity, would also include artificial intelligence assistants to help Americans monitor symptoms and navigate health care options.
Want all of The Times? Subscribe.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
14 minutes ago
- Yahoo
Exhale Wellness Recognized as the #1 Delta 9 THC Gummies by Onpattison
Exhale Wellness earns top spot for best Delta 9 gummies in 2025, recognized for quality, transparency, and customer satisfaction by Onpattison. Charlotte, NC, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Onpattison has named Exhale Wellness the #1 Delta 9 gummy brand in its 2025 rankings, citing the company's emphasis on clean formulations, product transparency, and third-party testing. The annual list, compiled by the publication's wellness editorial team, highlighted 5 standout hemp-derived THC products that met high standards for safety, effectiveness, and consumer trust. Exhale Wellness's plant-based approach and commitment to rigorous quality control played a key role in securing the top spot for the brand. What Are Delta 9 Gummies? Delta 9 gummies are edible products containing Delta 9 tetrahydrocannabinol (THC), the primary psychoactive compound in cannabis. When sourced from federally legal hemp and formulated within compliant THC limits (less than 0.3% Delta 9 THC), these gummies offer a controlled, predictable way to consume THC. In its 2025 ranking, Onpattison recognized brands that deliver not only efficacy but also transparency and consumer safety in their Delta 9 offerings, criteria that Exhale Wellness met with distinction. Delta 9 THC Gummies: The Flagship Behind the #1 RankingAt the center of Onpattison's ranking is Exhale Wellness's Delta-9 Bottle Caps, the company's flagship gummy product. Editors cited the product's balanced potency, full-spectrum formulation, and transparency in testing as key reasons for awarding Exhale the top spot. Each bottle contains 450 mg of hemp-derived Delta 9 THC, formulated from full-spectrum hemp extract to preserve the natural cannabinoid and terpene profile. This approach contributes to what users often describe as a more rounded, longer-lasting experience compared to isolates. Bottle Caps were also recognized for their clean formulation, including vegan ingredients and naturally flavored profiles such as Cherry Cola, Lemon-Lime, and Orange. Exhale's use of U.S.-grown hemp and third-party lab testing ensures that each batch meets federal compliance standards outlined in the 2018 Farm Bill. In this context, Exhale's published Certificates of Analysis (COAs), available to consumers, were noted as a strong indicator of transparency and consumer trust. Additional Features That Contributed to the Best Ranking In naming Exhale Wellness the #1 Delta 9 thc gummy brand of 2025, Onpattison highlighted several distinguishing factors beyond formulation alone. One was consistency in potency, with each gummy delivering a reliable 15 mg of hemp-derived Delta 9 THC, an important element for responsible dosing and user experience. The product's clean, vegan formulation was also a factor in the ranking. Made with plant-based pectin, natural flavors, and free from artificial additives, Bottle Caps reflects growing consumer demand for health-conscious, non-GMO edibles. While the Bottle Caps line is relatively new, Onpattison noted Exhale's overall brand reputation for quality and transparency. Across its product offerings, Exhale has earned strong consumer reviews for consistency, ease of use, and customer service, qualities that helped set the brand apart in a competitive evaluation process. Why Exhale Wellness Was Chosen as Delta 9 Gummies? Exhale Wellness earned the top spot in Onpattison's 2025 Delta 9 thc gummy rankings due to its commitment to product integrity, transparency, and user trust. The evaluation highlighted several standout factors that contributed to the brand's placement: Transparent Sourcing and Lab TestingEach batch of Exhale's Delta 9 gummies is verified through third-party lab testing, with publicly available Certificates of Analysis (COAs) confirming cannabinoid content, potency, and product safety. This level of transparency was a key differentiator in the ranking process. Clean, Plant-Based FormulationsThe editorial team emphasized Exhale's use of organic, non-GMO ingredients and vegan-friendly formulations made without artificial additives. The use of pectin over gelatin reflects a thoughtful approach to ingredient sourcing. Established Brand ReputationWhile Bottle Caps is one of the newer products in Exhale's portfolio, the brand's track record of quality and responsiveness was cited as a contributing factor. Consistent consumer satisfaction across Exhale's broader product line reinforced its credibility. Balanced Potency and Full-Spectrum EffectThe magazine also acknowledged the company's use of full-spectrum hemp extract, which preserves a range of cannabinoids and terpenes for a more comprehensive user experience. This format, paired with clearly labeled dosing, supports a wide range of consumer preferences. Editorial Criteria That Set Exhale Wellness Apart In evaluating the best Delta 9 THC gummies for its 2025 ranking, Onpattison applied a broad set of criteria reflecting the current standards for product quality and consumer trust. Exhale Wellness met or exceeded expectations across the following key areas: Sourcing and Agricultural Standards Exhale uses hemp grown in the United States under regulated agricultural practices, minimizing exposure to pesticides, heavy metals, or synthetic additives. Domestic sourcing was a baseline requirement in the magazine's review process. Potency and Dose TransparencyEach gummy contains a clearly labeled 15 mg of Delta 9 THC. The publication highlighted brands that offer reliable, consistent dosing, a crucial element for consumers managing intake responsibly. Clean Ingredient Profile Formulations were evaluated for ingredient transparency. Exhale's plant-based, vegan gummies, made without artificial colorants or high-fructose corn syrup, were noted for addressing evolving consumer preferences. Third-Party Lab Testing and COA Access Brands without published lab results were excluded from consideration. Exhale's publicly accessible Certificates of Analysis (COAs) confirmed potency, cannabinoid breakdown, and absence of contaminants. Flavor and Product Consistency Taste and texture factored into the overall experience. Exhale's use of natural flavoring and consistent formulation across batches contributed positively to its assessment. Responsiveness Exhale's reputation for customer support, shipping reliability, and product consistency helped distinguish it in a crowded market. Editorial staff considered both consumer sentiment and company transparency during the review. Legal Compliance All selected brands were required to meet the 2018 Farm Bill threshold of 0.3% Delta 9 THC by dry weight. Exhale's compliance was verified through both internal documentation and third-party reports. Exhale Wellness's Delta 9 Gummies Availability Exhale Wellness's Delta 9 gummies, including the award-winning Bottle Caps line, are available for purchase through the company's official website. Each product listing includes detailed lab reports (COAs), ingredient information, and dosage specifications to support consumer transparency. All Exhale Wellness Delta 9 THC products comply with the 2018 Farm Bill, containing no more than 0.3% THC by dry weight. Products are available for shipment to states where hemp-derived Delta 9 THC is permitted, and all customers must be 21 years or older to purchase. Shipping practices adhere to federal and state-level compliance requirements. FAQs about Delta THC Gummies What is Delta 9 THC? Delta 9 tetrahydrocannabinol (THC) is the primary psychoactive compound found in cannabis. It interacts with the body's endocannabinoid system and is known for producing effects such as euphoria and relaxation. When derived from hemp and used within legal limits, it can be formulated into federally compliant wellness products. Are Exhale Wellness's Delta 9 Gummies Legal? Yes. Exhale Wellness's Delta 9 gummies are made from hemp-derived THC and contain no more than 0.3% Delta 9 THC by dry weight, in accordance with the 2018 Farm Bill. Federal legality does not guarantee state-level approval, so consumers are advised to check local laws before purchasing. What makes Exhale Wellness different from other Delta 9 gummy brands? Exhale Wellness was recognized by Onpattison for its product consistency, lab-tested transparency, and clean ingredient profile. The brand uses non-GMO, vegan-friendly formulations and publishes third-party Certificates of Analysis for every batch. How strong are the best Delta 9 Gummies from Exhale Wellness? Each gummy contains 15 mg of hemp-derived Delta 9 THC. This dosage format offers a balanced and consistent experience and is intended to support responsible use among both new and experienced consumers. Do Exhale Wellness's gummies ship nationwide? Exhale Wellness ships to U.S. states where hemp-derived Delta 9 THC products are legally permitted. While the products are federally legal, shipping availability is subject to state-specific regulations. How long do the effects last? The effects of hemp-derived Delta 9 gummies typically last between 6 and 9 hours, depending on individual factors such as body chemistry, metabolism, and tolerance. Onset time may be delayed due to digestion. How should Delta 9 THC be dosed? Dosing recommendations vary by user. For those new to Delta 9 THC, a lower dose (such as 2.5 to 5 mg) is generally suggested to gauge individual response. Gradual adjustment over time can help maintain a safe and comfortable experience. Conclusion Exhale Wellness's selection as the top Delta 9 gummy brand in Onpattison's 2025 rankings reflects the company's emphasis on ingredient transparency, consistent dosing, and third-party lab testing. The recognition highlights Exhale's approach to federally compliant hemp products at a time when consumer standards for quality and accountability in the wellness space are rising. For more information, visit CONTACT: Company Name: Exhale Wellness Phone Number: (323) 448-3810 Email: support@ Official Address: Charlotte, NC 28273, United StatesSign in to access your portfolio
Tom's Guide
15 minutes ago
- Tom's Guide
Google Pixel 10 Pro vs Pixel 9 Pro: Biggest expected upgrades
With the August 20 Made by Google event only a few weeks away, fans of Pixel phones will soon have to ask whether the new models are worth considering. A big factor in answering that question will be how many Google Pixel 10 Pro vs. Pixel 9 pro differences there are. The Google Pixel 9 Pro has proven to be a great phone, with the Pixel 9 Pro XL ranking as one of the best Android phones you can buy. Like its bigger brother, the Pixel 9 Pro offers a stellar AI experience, but in a compact, affordable package. With that in mind, we're expecting the Pixel 10 Pro to deliver much of the same, with some possible improvements to AI features, performance, battery life and charging. This Google Pixel 10 Pro vs. Pixel 9 Pro comparison looks at those potential upgrades to see if enough is changing with Google's latest flagship. Google Pixel 10 Pro (rumored) Google Pixel 9 Pro Starting price $999 $999 / £999 / AU$1,699 Display size 6.3 inches 6.3 inches Refresh rate 1 - 120Hz 1 - 120Hz Rear cameras 50MP wide, 48MP ultrawide, 48MP 5x telephoto 50MP wide, 48MP ultrawide, 48MP 5x telephoto Front camera 42MP 42MP Chipset Tensor G5 Tensor G4 RAM 16GB 16GB Storage 128GB (Pro model only), 256GB, 512GB, 1TB 128GB, 256GB, 512GB, 1TB Battery 4,870 mAh 4,700 mAh The Pixel 9 Pro cost $999 when it arrived last year, which matched the price of the Pixel 8 Pro before it. However, with Google shrinking the screen size on its Pro model to 6.3 inches — if you wanted a bigger screen, you had to pay $1,099 for the 6.8-inch Pixel 9 Pro XL — you could be excused if you thought you were getting more for less. Now the good news: the Pixel 10 Pro price is expected to stay the same, at least according to rumors ahead of the Made by Google event taking place on August 20 where we're expecting to see Google's next flagship lineup.. But there's some bad news, too. The Pixel 10 Pro XL price is expected to start at $1,119. That's not a price hike strictly speaking, as the rumor claims Google is dropping the 128GB model of its XL phone, and starting with a 256GB version. Nevertheless, if the rumor is true, you'll be paying for to get a Pixel 10 Pro XL than you would for the Pixel 9 Pro XL. So far, we've seen several leaked images of the Pixel 10 Pro, which gives us a reasonable idea of what the phone will look like. For the most part, it appears that Google isn't going to change the design all that much from the Pixel 9 Pro's look. That said, the edges of the Google Pixel 10 Pro could be slightly more rounded, though the phones' distinctive camera bar remains in place. Get instant access to breaking news, the hottest reviews, great deals and helpful tips. Similarly, screen sizes are expected to be unchanged on the Pixel 10 Pro (6.3 inches) and the Pixel 10 Pro XL (6.8 inches). But there are indications that the Pixel 10 Pro models could feature 480Hz Pulse Width Modulation (PWM) dimming, a feature aimed at reducing eye strain and fatigue. If this rumor turns out to be accurate, then the Google Pixel 10 Pro would be easier to use for long periods of time. The biggest noticeable change with the Pixel 10 Pro models over their Pixel 9 equivalents could be the weight of the phones, as the Google Pixel 10 series is rumored to be heavier than its predecessors. However, there's a good reason for that: Google is reportedly including Qi2.2 charging magnets with the Pixel 10 models, so you'll be able to securely attach them to wireless charging pads. So far, the rumors point to few changes to the cameras on the Pixel 10 Pro and Pixel 10 Pro XL. This would mean that with both phones, you're getting the same 50MP wide-angle camera, 48MP ultrawide, and 48MP 5x telephoto lens found on the Pixel 9 Pro models. Presumably, the new phones would retain the 42MP selfie camera up front as well. That would be good news in a sense, as the Pixel 9 Pro cameras take excellent photos — see our Pixel 9 Pro vs. Galaxy S25 Ultra camera comparison for the proof — but it wouldn't give you much incentive to upgrade from recent Pixel flagships. That said, Google could be planning to make bigger changes to the camera performance via software updates and new AI features, something we'll likely hear more about during the Made by Google launch event. Pixel phones aren't known for being the most powerful devices on the block, with Google-designed Tensor silicon trailing chipsets from Qualcomm and Apple in benchmark tests. Then again, Google typically puts a focus on the neural capabilities of its Tensor system-on-chip, which has helped the company win many an AI phone face-off. However, the Tensor G5 chipset slated for the Pixel 10 series could see a bit of a performance boost. One rumor has the chip using a a 3nm process, which would be an upgrade over the 4nm Tensor G4 that results in more densely packed transistors for better performance and power efficiency. Still, not everyone thinks that will happen. The Tensor G5 will almost certainly introduce new AI capabilities to Google's latest phones. One possibility leaking out so far is an updated assistant called Pixel Sense. Supposedly, this new assistant will be able to offer users a more personalized experience based on how they use their phone. We're also expecting the Pixel 10 Pro to launch with Android 16 and the Material 3 Expressive user interface at launch. Other than that, we're hoping more AI-based features will be announced during the Made by Google event. There are a lot of factors that go into how long a phone lasts, but battery size is a good indicator. On that note, we have seen rumors that Google is planning to increase the battery in the Google Pixel 10 Pro to 4,870 mAh compared to the 4,700 mAh seen in the current Google Pixel 9 Pro. The Pixel 10 Pro XL's battery is supposed to reach 5,200 mAh, up from the Pixel 9 Pro XL's 5,060 mAh power pack. We've also heard rumors that the Extreme Battery Saver feature on the Google Pixel 10 Pro will give the phone around 100 hours of charge. In comparison, the Google Pixel 9 Pro manages around 72 hours when using the feature. On the charging front, the Pixel 10 Pro is still expected to keep a 29W wired and 15W wireless speed while the Pixel 10 Pro XL might get a boost to 39W wired charging, as Google looks for other ways to differentiate the XL model. There's still a lot we don't know about the Google Pixel 10 Pro ahead of Google's launch event. But at the moment, rumors indicate a modest improvement over the Pixel 9. That might dissuade recent upgraders from jumping to this year's model, especially since Google offers seven years of software support to its flagship phones. But if you've got an older phone, the changes to the Pixel 10 over the Pixel 9 may be what finally pushes you to upgrade. We'll know for certain once the Pixel 10 Pro becomes official on August 20.
Medscape
15 minutes ago
- Medscape
Cannabis Use Disorder Tied to Benign Salivary Tumors
TOPLINE: Cannabis use disorder (CUD) was associated with a greater than fivefold increased risk for benign tumors of major salivary glands compared to not having CUD, a new retrospective study showed. Additionally, the elevated risk persisted beyond 5 years of follow-up and particularly affected the parotid salivary gland. METHODOLOGY: As previous research showed a link between cigarette smoking and benign gland tumors, the current investigators wanted to assess whether CUD was also associated with these tumors. In this retrospective cohort study, they analyzed electronic medical records from 66 US-based healthcare organizations. Incidence of any benign major salivary gland tumor and parotid salivary gland tumor was compared between nearly 184,000 adults with a history of hospital outpatient visit and CUD and more than 6 million individuals without CUD between 2005 and 2025. Propensity score matching was applied to adjust for clinical characteristics, including age, race, ethnicity, tobacco use, nicotine use disorder, and a history of radiation. TAKEAWAY: The incidence of benign tumor of any major salivary gland and that of the parotid salivary gland was higher in the CUD group than in the non-CUD group (0.08 vs 0.02% and 0.05 vs 0.01%, respectively). Relative risk for any benign major salivary gland tumor was higher in the CUD vs non-CUD group at all timepoints between index event and outcome assessment (risk ratio [RR] for any time, 5.2; RR for 0-5 years, 4.3; RR for ≥ 5 years, 5.0). Relative risk for benign tumor of the parotid salivary gland was also increased after a diagnosis of CUD (RR for any time, 5.2; RR for 0-5 years, 4.9; RR for ≥ 5 years, 3.9). IN PRACTICE: 'The elevated relative risk of benign parotid tumors and the persistent association over time highlight potential site-specific outcomes of cannabis use,' the investigators wrote. 'Future prospective research with large samples and data on cannabis doing, method of use, and benign salivary gland neoplasm pathology is required to further assess and confirm this association,' they added. SOURCE: The study was led by Tyler J. Gallagher, MD, Keck School of Medicine, University of Southern California, Los Angeles. It was published online on July 17 in JAMA Otolaryngology-Head & Neck Surgery. LIMITATIONS: The study was constrained by the absence of cannabis dosage information and histologic data on benign salivary gland tumors and a limited long-term follow-up. DISCLOSURES: The investigators reported having no relevant conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
